X
Xeris Biopharma Holdings
XERS
2.43000
USD
-0.055
(-2.21%)
مفتوح الان
حجم التداول
13,904
الربح لكل سهم
0
العائد الربحي
0
P/E
-7
حجم السوق
447,741,469
الأخبار
العنوان: Xeris Biopharma Holdings
القطاع: Healthcare
الصناعة: Biotechnology
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.